Europe Deep Brain Simulation Market Forecast to 2030
Europe Deep Brain Simulation Market Forecast to 2030 – Regional Analysis – by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson’s Disease, Tremor, Dystonia, Epilepsy, Alzheimer’s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Demand for Minimally Invasive Surgery Drive Europe Deep Brain Simulation Market
Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson’s disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the Europe deep brain stimulation (DBS) market growth.
Europe Deep Brain Simulation Market Overview
In the medical field, neurosurgery requires advanced equipment and highly qualified medical professionals. German neurosurgeons are highly qualified specialists; they follow the latest protocols and surgical procedures. Neurology centers in Germany have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards. According to a study published at Charité—Universitätsmedizin Berlin entitled “Deep brain stimulation in Parkinson’s: A new algorithm to adjust stimulation settings has been developed,” Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s. Approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson’s. According to the German Association for Alzheimer’s Patients, in 2020, 9,450 people died from Alzheimer’s, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer’s diagnosis is highly dependent on the aging population in Germany. People aged 65 and above increased by ~33% between and reached 18.3 million in 2020. Therefore, the aging population results in growing neurological disorders, which is expected to boost the market growth in the coming years.
Europe Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
Europe Deep Brain Simulation Market Segmentation
The Europe deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the Europe deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the Europe deep brain simulation market.
Based on application, the Europe deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. In 2022, the Parkinson’s disease segment registered the largest share in the Europe deep brain simulation market.
Based on end user, the Europe deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the Europe deep brain simulation market.
Based on country, the Europe deep brain simulation market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. In 2022, Germany segment registered the largest share in the Europe deep brain simulation market.
Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, and Newronika SpA are some of the leading companies operating in the Europe deep brain simulation market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team Market research, the Europe deep brain simulation market was valued at US$ 169.14 million in 2022 and is expected to reach US$ 319.88 million by 2030, registering a CAGR of 8.3% from 2022 to 2030. Rising prevalence of neurological disorders and increasing demand for minimally invasive surgery are the critical factors attributed to the Europe deep brain simulation market expansion.
The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson’s disease, Alzheimer’s disease, and dystonia are among the most common neurological disorders affecting older people. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions such as deep brain stimulators (DBS). Therefore, growing awareness regarding the burden of neurological disorders, the growing geriatric population, and the increasing prevalence of neurological diseases propel the demand for deep brain stimulators as a therapy.
On the contrary, side effects associated with deep brain stimulation hurdles the growth of Europe deep brain simulation market.
Based on product, the Europe deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. The dual channel deep brain stimulator segment held 49.5% share of Europe deep brain simulation market in 2023, amassing US$ 83.77 million. It is projected to garner US$ 170.93 million by 2030 to expand at 9.3% CAGR during 2022–2030.
Based on application, the Europe deep brain simulation market is segmented into Parkinson’s disease, tremor, dystonia, epilepsy, Alzheimer’s disease, and others. The Parkinson’s disease segment held 69.3% share of Europe deep brain simulation market in 2023, amassing US$ 140.84 million. It is projected to garner US$ 267.21 million by 2030 to expand at 8.3% CAGR during 2022–2030.
Based on end user, the Europe deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. The hospitals segment held 56.4% share of Europe deep brain simulation market in 2022, amassing US$ 95.46 million. It is projected to garner US$ 188.97 million by 2030 to expand at 8.9% CAGR during 2022–2030.
Based on country, the Europe deep brain simulation market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 24.7% share of Europe deep brain simulation market in 2022. It was assessed at US$ 41.73 million in 2022 and is likely to hit US$ 81.51 million by 2030, exhibiting a CAGR of 8.7% during 2022–2030.
Key players operating in the Europe deep brain simulation market report Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corp, Medtronic Plc, and Newronika SpA, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe deep brain simulation market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Europe deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Europe Deep Brain Stimulation Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Deep Brain Simulation Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Comparison Analysis
4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
4.3.2 Lesioning Procedures in Neurological Disorders
4.3.3 Europe Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country
5. Europe Deep Brain Simulation Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Prevalence of Neurological Disorders
5.1.2 Increasing Demand for Minimally Invasive Surgery
5.2 Market Restraints
5.2.1 Side Effects Associated with Deep Brain Stimulation
5.3 Market Opportunities
5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact Analysis
6. Deep Brain Simulation Market – Europe Market Analysis
6.1 Europe Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
7. Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Europe Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Single Channel Deep Brain Stimulator
7.3.1 Overview
7.3.2 Single Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Dual Channel Deep Brain Stimulator
7.4.1 Overview
7.4.2 Dual Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software and Accessories
7.5.1 Overview
7.5.2 Software and Accessories: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Europe Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Parkinson’s Disease
8.3.1 Overview
8.3.2 Parkinson’s Disease: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tremor
8.4.1 Overview
8.4.2 Tremor: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer’s Disease
8.5.1 Overview
8.5.2 Alzheimer’s Disease: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Dystonia
8.6.1 Overview
8.6.2 Dystonia: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Epilepsy
8.7.1 Overview
8.7.2 Epilepsy: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Europe Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Neurology Clinics
9.4.1 Overview
9.4.2 Neurology Clinics: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Deep Brain Simulation Market – Country Analysis
10.1 Overview
10.1.1.1 Europe Deep Brain Simulation Market by Country
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Germany Deep Brain Simulation Market, by Product
10.1.1.2.4 Germany Deep Brain Simulation Market, by Application
10.1.1.2.5 Germany Deep Brain Simulation Market, by End User
10.1.1.3 UK
10.1.1.3.1 Overview
10.1.1.3.2 UK Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 UK Deep Brain Simulation Market, by Product
10.1.1.3.4 UK Deep Brain Simulation Market, by Application
10.1.1.3.5 UK Deep Brain Simulation Market, by End User
10.1.1.4 France
10.1.1.4.1 Overview
10.1.1.4.2 France Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 France Deep Brain Simulation Market, by Product
10.1.1.4.4 France Deep Brain Simulation Market, by Application
10.1.1.4.5 France Deep Brain Simulation Market, by End User
10.1.1.5 Italy
10.1.1.5.1 Overview
10.1.1.5.2 Italy Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Italy Deep Brain Simulation Market, by Product
10.1.1.5.4 Italy Deep Brain Simulation Market, by Application
10.1.1.5.5 Italy Deep Brain Simulation Market, by End User
10.1.1.6 Spain
10.1.1.6.1 Overview
10.1.1.6.2 Spain Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 Spain Deep Brain Simulation Market, by Product
10.1.1.6.4 Spain Deep Brain Simulation Market, by Application
10.1.1.6.5 Spain Deep Brain Simulation Market, by End User
10.1.1.7 Rest of Europe
10.1.1.7.1 Overview
10.1.1.7.2 Rest of Europe Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Rest of Europe Deep Brain Simulation Market, by Product
10.1.1.7.4 Rest of Europe Deep Brain Simulation Market, by Application
10.1.1.7.5 Rest of Europe Deep Brain Simulation Market, by End User
11. Pre & Post Covid-19 Impact
11.1 Pre & Post Covid-19 Impact
12. Europe Deep Brain Simulation Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in Deep Brain Stimulation Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Europe Deep Brain Simulation Market, Key Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Aleva Neurotherapeutics SA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medtronic Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Newronika SpA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Deep Brain Simulation Market Segmentation
Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
Table 3. Europe Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
Table 4. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 5. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 6. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 7. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 8. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 9. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 10. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 11. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 12. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 13. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 14. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 15. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 16. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 17. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 18. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 19. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 20. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 21. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. Recent Organic Growth Strategies in Deep Brain Stimulation Market
Table 23. Recent Inorganic Growth Strategies in the Europe deep brain simulation market
Table 24. Glossary of Terms, Europe Deep Brain Simulation Market
LIST OF FIGURES
Figure 1. Europe Deep Brain Simulation Market Segmentation, By Geography
Figure 2. Europe – PEST Analysis
Figure 3. Europe Deep Brain Simulation Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Deep Brain Simulation Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Europe Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Single Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Dual Channel Deep Brain Stimulator: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software and Accessories: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Europe Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Parkinson’s Disease: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Tremor: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Alzheimer’s Disease: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Dystonia: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurology Clinics: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Ambulatory Surgical Centers: Europe Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Deep Brain Simulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Europe Deep Brain Simulation Market, By Country, 2022 ($Mn)
Figure 23. Europe Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
Figure 24. Germany Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. UK Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. France Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Italy Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 28. Spain Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 29. Rest of Europe Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
Figure 30. Pre & Post Covid-19 Impact
Figure 31. Growth Strategies in Deep Brain Stimulation Market
The List of Companies – Europe Deep Brain Simulation Market
o Abbott Laboratories
o Aleva Neurotherapeutics SA
o Boston Scientific Corp
o Medtronic Plc
o Newronika SpA
You must be logged in to post a review.
Reviews
There are no reviews yet.